导师简介
导师姓名付强性别男出生年月1984.08导师类别硕导
研究方向药物制剂新技术提高难溶性药物口服吸收
联系电话**职称/院士讲师（破格硕导）
E-mailgraham_pharm@aliyun.com导师学位博士
学院（工作单位）药学院
信箱（地址）59号信箱

付强，男，博士，讲师，硕士生导师（破格）。2007年毕业于沈阳药科大学，获药剂学学士学位；2007-2012年于沈阳药科大学药剂系硕博连读，获药剂学博士学位；毕业后赴美国北卡大学教堂山分校分子药剂系进行博士后研究；回国后在沈阳药科大学药剂教研室任教，主要研究方向为药物制剂新技术提高难溶性药物口服吸收。

担任学术兼职、人才称号以及个人获奖

1. Asian Journal of Pharmaceutical Sciences，主编助理

2. 辽宁省百千万人才工程万人层次

3. International Journal of Pharmaceutics, International Journal of Nanomedicine, Current Drug Delivery等杂志审稿人

主持科研项目

1. 形态调控方法改善难溶性药物纳米结晶口服吸收的机制研究，国家自然科学基金委员会（**），2016.01—2018.12

2. 纳米结晶技术提高难溶性药物口服生物利用度，辽宁省博士科研启动基金 (No. **)，辽宁省科技厅，2014.07-2016.12

3. 棒状纳米结晶提高洛伐他汀口服生物利用度，辽宁省教育厅一般项目(No. L**)，辽宁省教育厅，2014.07--2016.12

4. 棒状纳米结晶口服给药系统的研究，沈阳药科大学青年教师事业发展支持计划，沈阳药科大学，2014.07--2016.12

5. 硼中子俘获治疗新模式：Angiopep 修饰脂质体对脑胶质瘤的靶向，沈阳药科大学青年教师科研启动资金（QNJJ**），2014.01—2015.12，已结题

代表性SCI论文(第一作者或通讯作者)

1. Jianwen Li, Chunli Luo, Dong Zhang, Mo Li, Qiang Fu*, Zhonggui He. Formulation and development of ternary hybrid matrix tablets of diltiazem hydrochloride. Powder Technology. 2016, 294: 66-70. (IF = 2.349)

2. Jianwen Li, Qiang Fu*, Xiaohong Liu, Mo Li, Yongjun Wang*. Formulation of nimodipine nanocrystals for oral administration. Archives of Pharmacal Research. 2016, 39: 202-212. (IF = 2.046)

3. Qiang Fu, Yongjun Wang*, Yan Ma, Dong Zhang, John K Fallon, Xinggang Yang, Dan Liu, Zhonggui He, Feng Liu. Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly. Scientific Reports. 2015, 5: 12023. (IF = 5.578)

4. Qiang Fu*, Bo Li, Dong Zhang, Mingming Fang, Jingbo Shao, Mengran Guo, Zhibin Guo, Mo Li, Jin Sun, Yinglei Zhai*. Comparative studies of the in vitro dissolution and in vivo pharmacokinetics for different formulation strategies (solid dispersion, micronization, and nanocrystals) for poorly water-soluble drugs: A case study for lacidipine. Colloids and Surfaces B: Biointerfaces. 2015, 132: 171-176. (IF = 4.152)

5. Mengran Guo, Qiang Fu*, Chunnuan Wu, Zhibin Guo, Mo Li, Jin Sun, Zhonggui He, Li Yang*. Rod shaped nanocrystals exhibit superior in vitro dissolution and in vivo bioavailability over spherical like nanocrystals: A case study of lovastatin. Colloids and Surfaces B: Biointerfaces. 2015, 128: 410-418. (IF = 4.152)

6. Dun Wang?, Qiang Fu? (?equal contribution), Jingling Tang, Michael Hackett, Yongjun Wang*, Feng Liu. Molecular-matched materials for anticancer drug delivery and imaging. Nanomedicine. 2015, 10(19): 3003-3013. (IF = 5.413)

7. Qiang Fu, Jin Sun*, Dong Zhang, Mo Li, Yongjun Wang, Guixia Ling, Xiaohong Liu, Yinghua Sun, Xiaofan Sui, Cong Luo, Le Sun, Xiaopeng Han, He Lian, Meng Zhu, Siling Wang, Zhonggui He*. Nimodipine nanocrystals for oral bioavailability improvement: Preparation, characterization and pharmacokinetic studies. Colloids and Surfaces B: Biointerfaces. 2013, 109: 161-166. (IF = 4.152)

8. Qiang Fu, Jin Sun*, Xiaoyu Ai, Peng Zhang, Mo Li, Yongjun Wang, Xiaohong Liu, Yinghua Sun, Xiaofan Sui, Le Sun, Xiaopeng Han, Meng Zhu, Yuyang Zhang, Siling Wang, Zhonggui He*. Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption. International Journal of Pharmaceutics. 2013, 448(1): 290-297. (IF = 3.65)

9. Jingling Tang?, Qiang Fu? (?equal contribution), Yongjun Wang, Kelly Racette, Dun Wang*, Feng Liu*. Vitamin E reverses multidrug resistance in vitro and in vivo. Cancer letters. 2013, 336(1): 149-157. (IF = 5.621)

10. Qiang Fu, Longfa Kou, Cheng Gong, Mo Li, Jin Sun*, Dong Zhang, Meina Liu, Xiaofan Sui, Kai Liu, Siling Wang, Zhonggui He*. Relationship between dissolution and bioavailability for nimodipine colloidal dispersions: The critical size in improving bioavailability. International Journal of Pharmaceutics. 2012, 427(2): 358-364. (IF = 3.65)

11. Qiang Fu, Jin Sun, Wenping Zhang, Xiaofan Sui, Zhongtian Yan, Zhonggui He*. Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Patents on Anti-Cancer Drug Discovery. 2009, 4(3): 262-272. (IF = 4.295)